4.7 Article

Partially fluorinated nanoemulsions for 19F MRI-fluorescence dual imaging cell tracking

Journal

COLLOIDS AND SURFACES B-BIOINTERFACES
Volume 215, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.colsurfb.2022.112493

Keywords

F-19 magnetic resonance imaging; Fluorescence imaging; Nanoemulsions; Paramagnetic effect; Cell tracking

Funding

  1. National Natural Science Foundation of China [22077098, 91859206]
  2. National Key R&D Program of China [2018YFA0704000]
  3. Natural Science Foundation of Hunan [2021JJ80015]
  4. Hunan Provincial Hengyang Joint Fund [2020JJ6052, 202150083704]

Ask authors/readers for more resources

This study introduces a novel dual imaging agent for cell tracking using partially fluorinated aromatic agents to formulate nanoemulsions for 19F MRI and fluorescence imaging. These agents have low density, high solubility, and short relaxation times, enabling the preparation of stable, biocompatible, and multifunctional nanoemulsions with high 19F MRI sensitivity. This approach may address issues associated with perfluorocarbons and provide a new strategy for high-performance 19F MRI agents.
Fluorine-19 magnetic resonance imaging (F-19 MRI) has been a technology of choice for in vivo cell tracking, in which perfluorocarbons (PFCs) nanoemulsions are the most used 19F MRI agents. However, the peculiar physicochemical properties of PFCs may lead to poor cell uptake and misleading cell tracking results. Herein, we employed partially fluorinated aromatic agents to formulate paramagnetic nanoemulsions as novel 19F MRIfluorescence (FL) dual imaging agents for cell tracking. With the intramolecular 7C-7C interaction, low density and fluorine content, the partially fluorinated agents enable considerable solubilities of functional agents and short relaxation times, which facilitates convenient preparation of stable, biocompatible, and multifunctional nanoemulsions with high 19F MRI sensitivity. Replacing PFCs in F-19 MRI nanoemulsions with readily available partially fluorinated aromatic agents may address many issues associated with PFCs and provide a novel strategy for high-performance 19F MRI agents of broad biomedical applications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available